82 related articles for article (PubMed ID: 20158191)
1. Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI.
Ono K; Ueda H; Yoshizawa Y; Akazawa D; Tanimura R; Shimada I; Takahashi H
J Med Chem; 2010 Mar; 53(5):2087-93. PubMed ID: 20158191
[TBL] [Abstract][Full Text] [Related]
2. EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis.
Grothusen C; Umbreen S; Konrad I; Stellos K; Schulz C; Schmidt B; Kremmer E; Teebken O; Massberg S; Luchtefeld M; Schieffer B; Gawaz M
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1184-90. PubMed ID: 17347483
[TBL] [Abstract][Full Text] [Related]
3. Convulxin forms a dimer in solution and can bind eight copies of glycoprotein VI: implications for platelet activation.
Horii K; Brooks MT; Herr AB
Biochemistry; 2009 Apr; 48(13):2907-14. PubMed ID: 19209849
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Glycoprotein VI Clustering by Collagen as a Mechanism of Inhibiting Collagen-Induced Platelet Responses: The Example of Losartan.
Jiang P; Loyau S; Tchitchinadze M; Ropers J; Jondeau G; Jandrot-Perrus M
PLoS One; 2015; 10(6):e0128744. PubMed ID: 26052700
[TBL] [Abstract][Full Text] [Related]
5. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding.
Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE
Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048
[TBL] [Abstract][Full Text] [Related]
6. Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro.
Muzard J; Bouabdelli M; Zahid M; Ollivier V; Lacapère JJ; Jandrot-Perrus M; Billiald P
FEBS J; 2009 Aug; 276(15):4207-22. PubMed ID: 19558491
[TBL] [Abstract][Full Text] [Related]
7. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
[TBL] [Abstract][Full Text] [Related]
8. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo.
Schulz C; Penz S; Hoffmann C; Langer H; Gillitzer A; Schneider S; Brandl R; Seidl S; Massberg S; Pichler B; Kremmer E; Stellos K; Schönberger T; Siess W; Gawaz M
Basic Res Cardiol; 2008 Jul; 103(4):356-67. PubMed ID: 18431526
[TBL] [Abstract][Full Text] [Related]
9. A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway.
Dunkley S; Arthur JF; Evans S; Gardiner EE; Shen Y; Andrews RK
Br J Haematol; 2007 Jun; 137(6):569-77. PubMed ID: 17539777
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the GPVI inhibitors losartan and honokiol.
Onselaer MB; Nagy M; Pallini C; Pike JA; Perrella G; Quintanilla LG; Eble JA; Poulter NS; Heemskerk JWM; Watson SP
Platelets; 2020; 31(2):187-197. PubMed ID: 30849265
[TBL] [Abstract][Full Text] [Related]
11. Platelet glycoprotein VI-related clinical defects.
Arthur JF; Dunkley S; Andrews RK
Br J Haematol; 2007 Nov; 139(3):363-72. PubMed ID: 17910626
[TBL] [Abstract][Full Text] [Related]
12. Novel synthetic collagen fibers, poly(PHG), stimulate platelet aggregation through glycoprotein VI.
Inoue O; Suzuki-Inoue K; Shinoda D; Umeda Y; Uchino M; Takasaki S; Ozaki Y
FEBS Lett; 2009 Jan; 583(1):81-7. PubMed ID: 19059245
[TBL] [Abstract][Full Text] [Related]
13. Platelet glycoprotein VI: its structure and function.
Moroi M; Jung SM
Thromb Res; 2004; 114(4):221-33. PubMed ID: 15381385
[TBL] [Abstract][Full Text] [Related]
14. Collagen-type specificity of glycoprotein VI as a determinant of platelet adhesion.
Jung SM; Takemura Y; Imamura Y; Hayashi T; Adachi E; Moroi M
Platelets; 2008 Feb; 19(1):32-42. PubMed ID: 18231936
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo evaluation of anti-GPVI antibody in cynomolgus monkeys: dissociation between anti-platelet aggregatory effect and bleeding time.
Matsumoto Y; Takizawa H; Nakama K; Gong X; Yamada Y; Tandon NN; Kambayashi J
Thromb Haemost; 2006 Aug; 96(2):167-75. PubMed ID: 16894460
[TBL] [Abstract][Full Text] [Related]
16. An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic resonance spectroscopy and theoretical calculations.
Mavromoustakos T; Kolocouris A; Zervou M; Roumelioti P; Matsoukas J; Weisemann R
J Med Chem; 1999 May; 42(10):1714-22. PubMed ID: 10346924
[TBL] [Abstract][Full Text] [Related]
17. A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.
Hermans C; Wittevrongel C; Thys C; Smethurst PA; Van Geet C; Freson K
J Thromb Haemost; 2009 Aug; 7(8):1356-63. PubMed ID: 19552682
[TBL] [Abstract][Full Text] [Related]
18. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome.
Bigalke B; Geisler T; Stellos K; Langer H; Daub K; Kremmer E; Seizer P; May AE; Lindemann S; Gawaz M
Am Heart J; 2008 Jul; 156(1):193-200. PubMed ID: 18585516
[TBL] [Abstract][Full Text] [Related]
19. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization.
Matsumoto Y; Takizawa H; Gong X; Le S; Lockyer S; Okuyama K; Tanaka M; Yoshitake M; Tandon NN; Kambayashi J
Thromb Res; 2007; 119(3):319-29. PubMed ID: 16566959
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands.
Snell DC; Schulte V; Jarvis GE; Arase K; Sakurai D; Saito T; Watson SP; Nieswandt B
Biochem J; 2002 Nov; 368(Pt 1):293-300. PubMed ID: 12117414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
